These are definitely the best of times for shareholders of a leading healthcare company in Nigeria, Neimeth International Pharmaceuticals Plc.
This is because the board of the company has proposed the issuance of bonus shares to shareholders for standing by the firm through turbulent period.
Neimeth International Pharmaceuticals is proposing to issue one new share for every 10 shares existing shares held by shareholders.
The firm noted that those who qualify for the bonus share are shareholders whose names appear in the register of members at the close of business on Thursday, January 17, 2019, subject to the approval of the appropriate regulatory authorities.
In a notice to the Nigerian Stock Exchange (NSE), the board said the register of shareholders will be closed from Friday, January 18, 2019 to reopen on Wednesday, January 23, 2019.
In the statement, Neimeth International Pharmaceuticals said on Wednesday, February 6, 2019, there would be an Annual General Meeting (AGM) at the Oranmiyan Hall, Lagos Airport Hotel, Ikeja, at 12 noon. The board said shareholders with dividend warrants and share certificates that have remained unclaimed, or are yet to be presented for payment or returned for validation are advised to complete the e-dividend registration or contact the registrar, Meristem Registrar and Probate Services Limited.
